Dorsey Wright & Associates Has $1.88 Million Stock Holdings in Relx Plc $RELX

Dorsey Wright & Associates trimmed its position in Relx Plc (NYSE:RELX) by 38.4% in the second quarter, Holdings Channel.com reports. The firm owned 34,650 shares of the technology company’s stock after selling 21,585 shares during the period. Dorsey Wright & Associates’ holdings in Relx were worth $1,883,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Larson Financial Group LLC lifted its position in Relx by 612.5% during the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock valued at $26,000 after purchasing an additional 441 shares during the period. WPG Advisers LLC acquired a new position in Relx in the first quarter valued at approximately $28,000. NewSquare Capital LLC boosted its stake in Relx by 522.0% in the second quarter. NewSquare Capital LLC now owns 566 shares of the technology company’s stock valued at $31,000 after acquiring an additional 475 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in Relx by 99.3% in the second quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock valued at $33,000 after acquiring an additional 303 shares during the last quarter. Finally, Harbor Asset Planning Inc. acquired a new stake in Relx during the 2nd quarter worth $37,000. 15.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Morgan Stanley restated an “overweight” rating on shares of Relx in a report on Thursday, September 11th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Relx in a research note on Thursday, November 13th. Finally, Barclays reiterated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy”.

Relx Trading Down 0.3%

NYSE RELX opened at $40.27 on Wednesday. Relx Plc has a 52 week low of $40.00 and a 52 week high of $56.33. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The stock’s 50 day moving average price is $45.21 and its two-hundred day moving average price is $49.52.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.